Emisphere Announces Third Quarter 2015 Financial Results Conference Call

ROSELAND, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that Management will host a conference call on Monday, November 16, 2015, at 8:30 AM ET to discuss the Company's financial and operational results for the third quarter ended September 30, 2015.

The live webcast of the conference call can be accessed through the Company's website at www.emisphere.com. The call can also be accessed by dialing (877) 303-9483 (United States and Canada) or (760) 666-3584 (international), and entering Conference ID# 78510550. In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning Monday, November 16, 2015, at 11:30 AM ET through 11:59 PM ET on December 6, 2015, by calling (855) 859-2056 (United States and Canada) or (404) 537-3406 (International), and entering Conference ID# 78510550.

About Emisphere

Emisphere is a commercial-stage specialty pharmaceutical and drug delivery company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12™, in the U.S. in March 2015 and is in partnership with global pharmaceutical companies to develop new formulations of existing products, as well as new chemical entities, using its Eligen® Technology. Beyond Eligen B12, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere's product pipeline includes prescription drug and medical food product candidates that are being developed in partnership or internally. For more information, please visit www.emisphere.com.

COMPANY CONTACTS: Alan L. Rubino, CEO 973.532.8000 arubino@emisphere.com Michael R. Garone, CFO 973.532.8005 mgarone@emisphere.com INVESTOR CONTACT: Susan Kim Argot Partners 212.600.1902 susan@argotpartners.com MEDIA CONTACT: Eliza Schleifstein Argot Partners 917.763.8106 eliza@argotpartners.com

Source:Emisphere Technologies, Inc.